RAPT Therapeutics, Inc.RAPTNASDAQ
Loading
Year-over-year operating income growth rate
Latest
0.84%
↑ 111% vs avg
Percentile
P53
Within normal range
Streak
1 qtr
Consecutive growthAccelerating
Average
-7.31%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.84% |
| Q2 2025 | -1.40% |
| Q1 2025 | 64.63% |
| Q4 2024 | -175.24% |
| Q3 2024 | 32.53% |
| Q2 2024 | 9.80% |
| Q1 2024 | 2.10% |
| Q4 2023 | 2.07% |
| Q3 2023 | -19.58% |
| Q2 2023 | 10.13% |
| Q1 2023 | -29.19% |
| Q4 2022 | -12.70% |
| Q3 2022 | -14.64% |
| Q2 2022 | 8.99% |
| Q1 2022 | -15.21% |
| Q4 2021 | 2.69% |
| Q3 2021 | -15.25% |
| Q2 2021 | 2.90% |
| Q1 2021 | -26.56% |
| Q4 2020 | 10.26% |
| Q3 2020 | -16.55% |
| Q2 2020 | 4.03% |
| Q1 2020 | -1.73% |
| Q4 2019 | -24.24% |
| Q3 2019 | 5.88% |
| Q2 2019 | -14.83% |
| Q1 2019 | 1.31% |
| Q4 2018 | 8.29% |
| Q3 2018 | -26.02% |
| Q2 2018 | -0.06% |
| Q1 2018 | 0.00% |